Alata Horticultural Research Institute, Mersin, Turkey.
Medical Faculty, Department of Gynecological Oncology, 63988Cukurova University, Adana, Turkey.
Eur J Mass Spectrom (Chichester). 2022 Feb;28(1-2):12-24. doi: 10.1177/14690667221098520. Epub 2022 May 3.
The aim of this study is to identify urinary metabolomic profile of benign and malign ovarian tumors patients. Samples were analyzed using gas chromatography-mass spectrometry (GC-MS) and metabolomic tools to define biomarkers that cause differentiation between groups. 7 metabolites were found to be different in patients with ovarian cancer (OC) and benign tumors (BT). R2Y and Q2 values were found to be 0.670 and 0.459, respectively. L-tyrosine, glycine, stearic acid, turanose and L-threonine metabolites were defined as prominent biomarkers. The sensitivity of the model was calculated as 90.72% and the specificity as 82.09%. In the pathway analysis, glutathione metabolism, aminoacyl-tRNA biosynthesis, glycine serine and threonine metabolic pathway, primary bile acid biosynthesis pathways were found to be important. According to the t-test, 29 metabolites were found to be significant in urine samples of OC patients and healthy controls (HC). R2Y and Q2 values were found to be 0.8170 and 0.749, respectively. These results showed that the model has high compatibility and predictive power. Benzoic acid, L-threonine, L-pyroglutamic acid, creatinine and 3,4-dihydroxyphenylacetic acid metabolites were determined as prominent biomarkers. The sensitivity of the model was calculated as 93.81% and the specificity as 98.59%. Glycine serine and threonine metabolic pathway, glutathione metabolism and aminoacyl-tRNA biosynthesis pathways were determined important in OC patients and HC. The R2Y, Q2, sensitivity and specificity values in the urine samples of BT patients and HC were found to be 0.869, 0.794, 91.75, 97.01% and 97.18%, respectively. L-threonine, L-pyroglutamic acid, benzoic acid, creatinine and pentadecanol metabolites were determined as prominent biomarkers. Valine, leucine and isoleucine biosynthesis and aminoacyl-tRNA biosynthesis were significant. In this study, thanks to the untargeted metabolomic approach and chemometric methods, every group was differentiated from the others and prominent biomarkers were determined.
本研究旨在鉴定良性和恶性卵巢肿瘤患者的尿液代谢组学特征。采用气相色谱-质谱联用(GC-MS)和代谢组学工具对样本进行分析,以确定区分各组的生物标志物。发现卵巢癌(OC)和良性肿瘤(BT)患者有 7 种代谢物存在差异。R2Y 和 Q2 值分别为 0.670 和 0.459。L-酪氨酸、甘氨酸、硬脂酸、棉子糖和 L-苏氨酸代谢物被定义为显著的生物标志物。模型的灵敏度计算为 90.72%,特异性为 82.09%。在途径分析中,发现谷胱甘肽代谢、氨酰-tRNA 生物合成、甘氨酸丝氨酸和苏氨酸代谢途径、初级胆汁酸生物合成途径很重要。根据 t 检验,在 OC 患者和健康对照(HC)的尿液样本中发现 29 种代谢物有显著差异。R2Y 和 Q2 值分别为 0.8170 和 0.749。这些结果表明,该模型具有较高的兼容性和预测能力。苯甲酸钠、L-苏氨酸、L-焦谷氨酸、肌酐和 3,4-二羟基苯乙酸代谢物被确定为显著的生物标志物。模型的灵敏度计算为 93.81%,特异性为 98.59%。在 OC 患者和 HC 中,甘氨酸丝氨酸和苏氨酸代谢途径、谷胱甘肽代谢和氨酰-tRNA 生物合成途径被确定为重要途径。BT 患者和 HC 的尿液样本中 R2Y、Q2、灵敏度和特异性值分别为 0.869、0.794、91.75%和 97.01%、97.18%。L-苏氨酸、L-焦谷氨酸、苯甲酸钠、肌酐和十五烷醇代谢物被确定为显著的生物标志物。缬氨酸、亮氨酸和异亮氨酸生物合成和氨酰-tRNA 生物合成是显著的。在这项研究中,由于采用了非靶向代谢组学方法和化学计量学方法,每个组都与其他组区分开来,并确定了显著的生物标志物。